CenterGate Capital has invested in Canadian Dental Labs (CDL), a Toronto-based operator of eleven dental laboratories across Canada. The company manufactures fixed and removable prosthetics along with orthodontic appliances for dental practices nationwide. CDL plans to deploy the capital toward expanding its workforce and upgrading technology across its laboratory network.

The deal signals continued private equity interest in dental services consolidation, a fragmentated sector where scale advantages in procurement, digital workflow integration, and technician recruitment drive margin expansion. CenterGate's strategy typically targets founder-owned businesses in healthcare and business services with EBITDA between $3 million and $15 million, suggesting CDL fits a platform-building thesis.

No financial terms were disclosed, but the investment positions CDL to pursue add-on acquisitions in a Canadian market where independent labs face pressure from digital dentistry adoption and rising labor costs. Larger networks can amortize scanner, milling, and 3D-printing investments across higher case volumes.

For investors, the transaction underscores a broader roll-up pattern: financial sponsors acquiring regional lab operators, standardizing digital workflows, and selling to strategic buyers or larger platforms at higher multiples. The Canadian market, with its single-payer adjacent reimbursement structure, presents distinct regulatory and pricing dynamics compared to U.S. counterparts.